BAX

#818
Baxter International Inc. Common Stock
18.8 0 USD
-2.29%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
18.77
19.01
Годовой диапазон
15.73
32.04
Дневное изменение
-2.29%
Месячное изменение
+6.03%
6-месячное изменение
+1.35%
Годовое изменение
-38.18%
Предыдущее закрытие
19.2 4
Open
18.8 8
Low
18.7 7
High
19.0 1
Volume
2 194
Открыть полный график Full chart

Financials

Обзор Отчетность Статистика Дивиденды
Квартал Год
  • Market Capitalization 9.71 B
  • Employee 38 K
  • Founded N/A
  • CEO Andrew Hider
  • Website www.baxter.com
  • Headquarter Delaware, United States
  • FIGI BBG000BCVJ77
  • Industry Медицинские инструменты и расходники
Общий доход
Чистая прибыль
Базовая прибыль на акцию
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Коэффициент цена/прибыль
-7.81
Коэффициент цена/денежный поток
0.76
Дивиденды на акцию
0.01
Дивидендная доходность, %
5.18

Baxter International Inc. Common Stock

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals. Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients. Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services". Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology.

Новости